Clinical Trials Browser

Phase 2 × Pituitary Diseases × 1 year × Clear all

NCT05199584 2026-03-05

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

CNSDermatologicEndocrineHead & NeckOther solid neoplasmSarcomaThoracic

Uveal Melanoma, Glioma, Adenoma, Islet Cell, Laryngeal Diseases, Medulloblastoma, Melanoma, Mesothelioma, Neuroblastoma, Pituitary Diseases, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma

NCT04042753 2025-08-08

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

Phase 2 Active not recruiting

9 enrolled

Endocrine

Pituitary Diseases, Pituitary Neoplasms